Abpro

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. Evelo Biosciences, Inc. (EVLO) will issue more than 5.3 million shares between $15 and $17 Wednesday on the Nasdaq. The Massachusetts pharmaceutical company is developing monoclonal microbial candidates to treat cancer...

After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) pulled back this week amid some not-so-encouraging earnings reports and negative regulatory decisions. Will the lean trot end? Stay tuned to the upcoming week's...